Skip to main content
SpringerLink
Log in

General Aspects of Worldwide HRT Use

  • Conference paper
Hormone Replacement Therapy and Osteoporosis

Part of the book series: Ernst Schering Research Foundation Workshop ((3368,volume 4))

Abstract

The general impression is that the human lifespan is increasing. The lifespan is the biological limit to life; it is the maximum age obtainable by a member of a species. There is a statistical variance from this for individuals, but overall, lifespan is finite. What is really increasing is the life expectancy rather than the lifespan. An analysis of the average life expectancy indicates that death converges at a certain maximum age. Thus, the number of older people is increasing, but it will eventually reach a fixed limit. The time spent in old age will make up an increasing percentage of a typical life, as we have nearly eliminated premature death. The reason for this success is a virtual eradication of previously fatal infectious diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Balfour JA, McTavish D (1992) Transdermal estradiol: a review of its pharmacological profile, and therapeutic potential in the prevention of postmenopausal osteoporosis. Drugs Aging 2: 487–507

    Article  PubMed  CAS  Google Scholar 

  • Barrett-Connor E (1997) Menopause: Problems and interventions in the United States. In: Paoletti R, Crosignani PG, Kenemans P, Samsioe G, Soma M, Jackson AS (eds) Women’s health and menopause. Kluwer, Dordrecht, pp 9–13

    Chapter  Google Scholar 

  • Beresford SAA, Weiss NS, Voigt LF, McKnight B (1997) Risk of endometrial cancer in relation to use of estrogen combined with cyclic progestogen therapy in postmenopausal women. Lancet 359: 458–461

    Article  Google Scholar 

  • Brincat M, Moniz CJ, Studd JWW, Darby A, Magos A, Emburey G, Versi E (1985) Long-term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynaecol 92: 256–259

    Article  PubMed  CAS  Google Scholar 

  • Caine M (1977) The importance of adrenergic receptors in disorders of micturition. Eur Urol 3: 1–6

    PubMed  CAS  Google Scholar 

  • Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer. Lancet 350: 1047–1059

    Google Scholar 

  • Creasman WT (1991) Estrogen replacement therapy: is previously treated cancer a contra-indication? Obstet Gynecol 77: 308–312

    Article  PubMed  CAS  Google Scholar 

  • Delmas PD, Bjarnason NH, Mitlak BH, Ravoux AC, Shah AS, Huster WJ, Draper M, Christiansen C (1997) The effects of raloxifene on bone mineral density, serum cholesterol, and uterine endometrium. N Engl J Med 337: 1641–1647

    Article  PubMed  CAS  Google Scholar 

  • Dören M, Reuther G, Minne HW, Schneider HPG (1995) Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women. Am J Obstet Gynecol 173: 1446–1451

    Article  PubMed  Google Scholar 

  • Dören M, Schneider HPG (1996) The impact of different HRT regimens on compliance. Int J Fertil 41: 29–39

    Google Scholar 

  • Eiken P, Kolthoff N (1995) Compliance with long-term oral hormonal replacement therapy. Maturitas 22: 97–103

    Article  PubMed  CAS  Google Scholar 

  • Fanth JA, Cardozo L, McClish D (1994) Estrogen therapy in the management of urinary incontinence in postmenopausal women: a metaanalysis. Obstet Gynecol 83: 12

    Google Scholar 

  • Ferguson KJ, Hoegh C, Johnson S (1989) Estrogen replacement therapy: a sur-vey of women’s knowledge and attitudes. Arch Intern Med 149: 133–136

    Article  PubMed  CAS  Google Scholar 

  • Fleisch H (1997) Bisphosphonates in bone disease, 3rd edn. Parthenon, New York, pp 1–184

    Google Scholar 

  • Fries JF (1980) Aging, natural death and the compression of morbidity. N Engl J Med 303: 130

    Article  PubMed  CAS  Google Scholar 

  • Fries JF (1988) Aging, illness, and health policy: implications of the compression of morbidity. Perspect Biol Med 31: 407

    PubMed  CAS  Google Scholar 

  • Fries JF, Green LW, Levine S (1989) Health promotion and the compression of morbidity. Lancet 1: 481

    Article  PubMed  CAS  Google Scholar 

  • Funk JL, Mortel KF, Meyer JS (1991) Effects of estrogen replacement therapy on cerebral perfusion and cognition among postmenopausal women. Dementia 2: 268–272

    Google Scholar 

  • Grisso JA, Kelsey JL, Strom BL et al. (1991) Risk factors for falls as a cause of hip fracture in women. N Engl J Med 324: 326–331

    Article  Google Scholar 

  • Herrington DM, Fong J, Sempos CT et al. (1998) Comparison of the HERS cohort with women with coronary heart disease from the NHANES III Survey. Am Heart J 136: 115–124

    Article  PubMed  CAS  Google Scholar 

  • Hope S, Rees MCP, Radcliffe J (1995) Why do British women start and stop hormone replacement therapy? J Br Menopause Soc 12: 16–17

    Google Scholar 

  • Jaglal SB, Kreiger N, Darlington G (1993) Past and present physical activity and risk of hip fracture. Am J Epidemiol 138: 107–118

    PubMed  CAS  Google Scholar 

  • Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Lingle DD, Metter E (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer’s disease: the Baltimore Longitudinal Study of Aging. Neurology 48: 1517–1521

    Article  PubMed  CAS  Google Scholar 

  • Kiel DP, Felson DT, Andersen JJ, Wilson PWF, Moskowitz MA (1987) Hip fracture and the use of estrogens in postmenopausal women. The Framingham study. N Engl J Med 317: 1169–1174

    Google Scholar 

  • Persson I, Adami H-O, Bergquist L et al. (1989) Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective survey. Br Med J 298: 147–151

    Article  CAS  Google Scholar 

  • Rodin J (1986) Aging and health: effects of the sense of control. Science 233: 1271

    Article  PubMed  CAS  Google Scholar 

  • Schneider HPG (1997) Cross-national study of women’s use of hormone replacement therapy (HRT) in Europe. Int J Fertil 42 (Suppl 2): 365–375

    Google Scholar 

  • Schneider HPG, Dören M (1996) Traits for long-term acceptance of hormone replacement therapy–results of a representative German survey. Eur Menopause J 3 (Suppl 2): 94–98

    Google Scholar 

  • Seto TB, Taira DA, Davis RB, Safran C, Phillips RS (1996) Effect of physician gender on the prescription of estrogen replacement therapy. J Gen Intern Med 11: 197–203

    Article  PubMed  CAS  Google Scholar 

  • Sherwin BB (1994) Estrogenic effects on memory in women. Ann NY Acad Sci 734: 213–230

    Article  Google Scholar 

  • Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Maÿeux R (1996) Effect of estrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet 348: 429–432

    Article  PubMed  CAS  Google Scholar 

  • Weiss NS, Ure CL, Ballard JH, Williams AR, Dalin JR (1980) Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Eng1 J Med 303: 1195–1198

    Article  CAS  Google Scholar 

Download references

Authors
  1. H. P. G. Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Teikyo Heisei Junior College, 6-29-1 Ichiharadai, 290-0192, Ichihara-shi, Chiba, Japan

    J. Kato

  2. Minaguchi Hospital, 1-7-7 Minamicho, 180-0003, Kichijoji Musashino-shi, Tokyo, Japan

    H. Minaguchi

  3. Preclinical Development Department, Nihon Schering K.K., 6-64, Nishimiyahara 2-Chome, 532-0004, Yodogawa-ku, Osaka-shi, Osaka, Japan

    Y. Nishino

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schneider, H.P.G. (2000). General Aspects of Worldwide HRT Use. In: Kato, J., Minaguchi, H., Nishino, Y. (eds) Hormone Replacement Therapy and Osteoporosis. Ernst Schering Research Foundation Workshop, vol 4. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-04021-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-04021-8_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-04023-2

  • Online ISBN: 978-3-662-04021-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation